secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADC Therapeutics SA (ADCT)
CIK:        0001771910
Form:       8-K
Filed at:   2024-01-04T23:59:59+00:00
Accession:  0000950103-24-000237
Event type: other
Sentiment:  positive
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ADC Therapeutics regains NYSE minimum bid price compliance; removed from noncompliant list
--------------------------------------------------------------------------------

- Received NYSE notice on Jan 2, 2024 confirming compliance with Section 802.01C.
- Cure: closing price on Dec 29, 2023 and 30-trading-day average both above $1.00.
- Previously noncompliant due to average closing price below $1.00 over 30 days.
- Company will be removed from NYSE's noncompliant issuers list.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324000237/0000950103-24-000237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324000237/dp204732_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-000237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer